Skip to main content
a b c d e f g h i j k l m n o p q r s t u v w x y z #

Items starting with C

C-Peptide (Urine)

C-Peptide (Urine)

Provided by referral laboratory

UCPCR <0.2 nmol/mmol: Severe insulin deficiency

UCPCR 0.2 -0.6 nmol/mmol: Intermediate insulin secretion

UCPCR >0.6 nmol/mmol: Substantial endogenous insulin secretion

C peptide ranges 2 1024x620

 

C-Reactive Protein (CRP)

C-Reactive Protein (CRP)

0-5 mg/L

(Source : Abbott Diagnostics)

Concentration of up to 5 mg/L exclude many acute inflammatory diseases, but do not specifically exclude inflammatory processes.

Values in excess of 100mg/L show acute bacterial infection or active inflammation.

C1 esterase inhibitor

C1 esterase inhibitor

0.15-0.35g/L

PRU handbook in clinical Immunochemistry . A.Milford Ward. J.Sheldon et al 9th edition. 2007

Cadmium

Cadmium

Cadmium (blood) (CAD)

nmol/L

Non-smokers

<27

Smokers

<54

Significant Exposure

>90

Source, SAS Trace Element Laboratories Update 2018

 

Calcitonin

Calcitonin

Females <5.5 ng/L
Males < 18.9 ng/L
(New reference range July 2006 - Diasorin assay)

Calcium

Calcium

Neonate (<4wks)  2.0-2.7 mmol/L

4wks-16yrs          2.2-2.7 mmol/L

Adult                   2.2-2.6 mmol/L

(Source : Pathology Harmony Recommendations)

Calprotectin (faecal)

Calprotectin (faecal)

Reference ranges from 17/10/2016 (NB: reference range only applicable to adult patients):

≤60ug/g: Not indicative of GI inflammation

>60ug/g but ≤ 150ug/g: Moderately elevated levels are associated with organic intestinal disease but should be interpreted in line with clinical assessment. Repeat FCALP in 4 weeks from first test and stop aspirin/NSAIDs. If this is the repeat test please refer for ‘new IBD’ clinic appointment.

>150ug/g: Elevated calprotectin suggestive of but not diagnostic of inflammatory bowel disease. Please refer for ‘new IBD’ clinic appointment.

Please see guidelines for adult patients below:

Cancer Antigen 125 (CA 125)

Cancer Antigen 125 (CA 125)

Population Reference Range used historically at BHH < 30 kU/L.

Manufacturers reference data. Roche Diagnostics June 2006:

593 pre- and post-menopausal healthy females yielded a 95th centile value of 35 kU/L.
It is suggested that a value of > 35 kU/L indicates that disease may still be present when used in the context of detection of residual or recurrent ovarian carcinoma following first line treatment.

Carbamazepine

Carbamazepine

Therapeutic range: 4-12 mg/L

Source : Pathology Harmony Recommendations

Nystagmus, ataxia and drowsiness occur at levels above 12 mg/L and more serious toxicity above 15 mg/L.

[12 3 4 5  >>